Pancreatic Cancer

- Research gaps

▪️ Systematic inclusion of cost-benefit analyses in clinical trials with collection of health economic analysis such as incremental cost effectiveness ratio in order to facilitate clinical decision-making. 

▪️  Predictive biomarkers: response to specific systemic targeted therapies and immunotherapy. 

▪️  Improve models for pre-clinical testing of novel drugs. 

▪️  Search for tools to assess quality of life and in clinical trials.

▪️ Dietary supplements, nutritional counselling, physical activity recommendations and psychological support as part of an integrative healthcare approach to care for people with pancreatic cancer.